Research Use Only - Important Disclaimer
All products listed on this website are intended for laboratory research use only and are not for human consumption, medical, veterinary, or household use. These products should only be handled by qualified professionals. We do not provide any dosage information, and the products must not be used as food additives, drugs, cosmetics, or for any other inappropriate applications. By purchasing, you acknowledge and agree to these terms.
FOX04-DRI (10 mg)
Senolytic Peptide
FOX04‑DRI (Retro‑Inverso) is a synthetic peptide designed to interfere with the FOXO4/p53 interaction, enabling selective induction of apoptosis in senescent cells to improve tissue function and biological age.
Usage:
Used in research to remove senescent cells and study aging, tissue regeneration, insulin signaling, and cell cycle control.
Mechanism of Action:
Acts as a cell‑penetrating peptide that disrupts FOXO4 binding to p53, freeing p53 to induce apoptosis in senescent cells.
Benefits:
- Selective clearance of senescent cells
- Improved organ and tissue function
- Reduced aging‑related inflammatory signaling
- Enhanced insulin sensitivity and metabolic outcomes
Side Effects:
- Limited human safety data
- Potential off‑target effects in non‑senescent cells
Suggested Dosage:
Not specified
Half-life: Prolonged compared to native FOXO4 peptide (due to retro‑inverso design)
Delivery: Subcutaneous injection (after reconstitution in bacteriostatic water or suitable solvent)